Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec;71(6):1218-33.
doi: 10.1016/j.jaad.2014.08.038. Epub 2014 Sep 26.

Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches

Robert Sidbury  1 , Wynnis L Tom  2 , James N Bergman  3 , Kevin D Cooper  4 , Robert A Silverman  5 , Timothy G Berger  6 , Sarah L Chamlin  7 , David E Cohen  8 , Kelly M Cordoro  6 , Dawn M Davis  9 , Steven R Feldman  10 , Jon M Hanifin  11 , Alfons Krol  11 , David J Margolis  12 , Amy S Paller  7 , Kathryn Schwarzenberger  13 , Eric L Simpson  11 , Hywel C Williams  14 , Craig A Elmets  15 , Julie Block  16 , Christopher G Harrod  17 , Wendy Smith Begolka  18 , Lawrence F Eichenfield  2
Affiliations

Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches

Robert Sidbury et al. J Am Acad Dermatol. 2014 Dec.

Abstract

Atopic dermatitis is a common, chronic inflammatory dermatosis that can affect all age groups. This evidence-based guideline addresses important clinical questions that arise in its management. In this final section, treatments for flare prevention and adjunctive and complementary therapies and approaches are reviewed. Suggestions on use are given based on available evidence.

Keywords: aeroallergens; allergy testing; atopic dermatitis; calcineurin inhibitors; complementary therapy; corticosteroids; diet; education; flare; food allergy; topicals.

PubMed Disclaimer

References

    1. Nankervis H, Maplethorpe A, Williams HC. Mapping randomized controlled trials of treatments for eczema--the GREAT database (the Global Resource of EczemA Trials: a collection of key data on randomized controlled trials of treatments for eczema from 2000 to 2010) BMC dermatology. 2011;11:10. - PMC - PubMed
    1. Hanifin JM, Cooper KD, Ho VC, Kang S, Krafchik BR, Margolis DJ, et al. Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association “Administrative Regulations for Evidence-Based Clinical Practice Guidelines”. J Am Acad Dermatol. 2004;50:391–404. - PubMed
    1. Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C, et al. Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol. 2012;26:1045–60. - PubMed
    1. Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C, et al. Guidelines for treatment of atopic eczema (atopic dermatitis) Part II. J Eur Acad Dermatol Venereol. 2012;26:1176–93. - PubMed
    1. Schneider L, Tilles S, Lio P, Boguniewicz M, Beck L, LeBovidge J, et al. Atopic dermatitis: a practice parameter update 2012. J Allergy Clin Immunol. 2013;131:295–9 e1-27. - PubMed

Publication types

MeSH terms

Substances